Pigment Cell & Melanoma Research

© John Wiley & Sons A/S. Published by John Wiley & Sons Ltd

Cover image for Vol. 26 Issue 3

Early View (Online Version of Record published before inclusion in an issue)

Edited by: Marcus Bosenberg and Heinz Arnheiter - Reviews Editor: Robert Kelsh

Impact Factor: 5.059

ISI Journal Citation Reports © Ranking: 2011: 2/58 (Dermatology); 32/196 (Oncology); 51/181 (Cell Biology)

Online ISSN: 1755-148X

  1. Corrigendum

    1. You have free access to this content
      Corrigendum

      Article first published online: 23 MAY 2013 | DOI: 10.1111/pcmr.12112

      This article corrects:

      An ERBB3/ERBB2 oncogenic unit plays a key role in NRG1 signaling and melanoma cell growth and survival

      Vol. 26, Issue 3, 408–414, Article first published online: 2 APR 2013

  2. Signaling & Cell biology

    1. Original Articles

      MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL

      Kathryn A. Tworkoski, James T. Platt, Antonella Bacchiocchi, Marcus Bosenberg, Titus J. Boggon and David F. Stern

      Article first published online: 21 MAY 2013 | DOI: 10.1111/pcmr.12110

  3. Microenvironment & Immunology

    1. Perspectives

      T cell immunotherapy for melanoma from bedside to bench to barn and back: how conceptual advances in experimental mouse models can be translated into clinical benefit for patients

      Thomas Tüting

      Article first published online: 15 MAY 2013 | DOI: 10.1111/pcmr.12111

  4. Original Articles

    1. You have full text access to this OnlineOpen article
      Genetic modulation of the iris transillumination defect: a systems genetics analysis using the expanded family of BXD glaucoma strains

      Shankar Swaminathan, Hong Lu, Robert W. Williams, Lu Lu and Monica M. Jablonski

      Article first published online: 13 MAY 2013 | DOI: 10.1111/pcmr.12106

  5. Signaling & Cell Biology

    1. Original Articles

      Secondary c-Kit mutations confer acquired resistance to RTK inhibitors in c-Kit mutant melanoma cells

      Jason R. Todd, Therese M. Becker, Richard F. Kefford and Helen Rizos

      Article first published online: 13 MAY 2013 | DOI: 10.1111/pcmr.12107

  6. Microenvironment & Immunology

    1. Short Communications

      Decreased regulatory T-cells and CD4+/CD8+ ratio correlate with disease onset and progression in patients with generalized vitiligo

      Mitesh Dwivedi, Naresh C. Laddha, Prateek Arora, Yogesh S. Marfatia and Rasheedunnisa Begum

      Article first published online: 13 MAY 2013 | DOI: 10.1111/pcmr.12105

  7. Meeting Reports

    1. Meeting report from the Society for Melanoma Research 2012 Congress, Hollywood, California

      R. S. Lo, A. Ribas, G. V. Long, R. Ballotti, M. Berger, H. Willy, G. T. Gibney, M. Bosenberg, E. Bernstein, J. Villanueva and K. S. M. Smalley

      Article first published online: 13 MAY 2013 | DOI: 10.1111/pcmr.12103

  8. Signaling & Cell Biology

    1. Original Articles

      Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment, and on progression

      Georgina V. Long, James S. Wilmott, Lauren E. Haydu, Varsha Tembe, Raghwa Sharma, Helen Rizos, John F. Thompson, Julie Howle, Richard A. Scolyer and Richard F. Kefford

      Article first published online: 3 MAY 2013 | DOI: 10.1111/pcmr.12098

    2. Short Communications

      Resistance to cisplatin-induced cell death conferred by the activity of organic anion transporting polypeptides (OATP) in human melanoma cells

      Françoise Silvy, Jean-Claude Lissitzky, Nadine Bruneau, Nathalie Zucchini, Jean-François Landrier, Dominique Lombardo and Patrick Verrando

      Article first published online: 3 MAY 2013 | DOI: 10.1111/pcmr.12108

  9. Microenvironment & Immunology

    1. Perspectives

      Ret transgenic mouse model of spontaneous skin melanoma: focus on regulatory T cells

      Viktor Umansky and Alexandra Sevko

      Article first published online: 25 APR 2013 | DOI: 10.1111/pcmr.12104

  10. Development & Stem cells

    1. Short Communications

      Chk1 is essential for the development of murine epidermal melanocytes

      Joanne Smith, Lionel Larue and David A. Gillespie

      Article first published online: 17 APR 2013 | DOI: 10.1111/pcmr.12100

  11. Signaling & Cell Biology

    1. Original Articles

      Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma

      Linda Gao, Marjon A. Smit, Joost J. van den Oord, Jelle J. Goeman, Els M. E. Verdegaal, Sjoerd H. van der Burg, Marguerite Stas, Samuel Beck, Nelleke A. Gruis, Cornelis P. Tensen, Rein Willemze, Daniel S. Peeper and Remco van Doorn

      Article first published online: 17 APR 2013 | DOI: 10.1111/pcmr.12096

  12. News and Views

    1. How the leopard gets its spots: a transmembrane peptidase specifies feline pigmentation patterns

      Ian J. Jackson

      Article first published online: 17 APR 2013 | DOI: 10.1111/pcmr.12101

  13. Experimental therapeutics/Preclinical

    1. Original Articles

      E-cadherin determines Caveolin-1 tumor suppression or metastasis enhancing function in melanoma cells

      Lorena Lobos-González, Lorena Aguilar, Jorge Diaz, Natalia Diaz, Hery Urra, Vicente A. Torres, Veronica Silva, Christopher Fitzpatrick, Alvaro Lladser, Keith S. Hoek, Lisette Leyton and Andrew F. G. Quest

      Article first published online: 11 APR 2013 | DOI: 10.1111/pcmr.12085

  14. Signaling & Cell Biology

    1. Original Articles

      Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas

      Janine L. Oliver, Matthew P. Alexander, Allison G. Norrod, Irene M. Mullins and David W. Mullins

      Article first published online: 11 APR 2013 | DOI: 10.1111/pcmr.12091

  15. Resource

    1. You have free access to this content
      The Ludwig Institute for Cancer Research Melbourne Melanoma Cell Line Panel

      Andreas Behren, Matthew Anaka, Pu-Han Lo, Laura J. Vella, Ian D. Davis, Jenny Catimel, Tracy Cardwell, Craig Gedye, Christopher Hudson, Rodica Stan and Jonathan Cebon

      Article first published online: 11 APR 2013 | DOI: 10.1111/pcmr.12097

  16. Experimental therapeutics/Preclinical

    1. Original Article

      Selective RAF inhibitor impairs ERK1/2 phosphorylation and growth in mutant NRAS, vemurafenib-resistant melanoma cells

      Kaitlyn Le, Erik S. Blomain, Ulrich Rodeck and Andrew E. Aplin

      Article first published online: 8 APR 2013 | DOI: 10.1111/pcmr.12092

  17. Meeting Reports

    1. Meeting report: The future of preclinical mouse models in melanoma treatment is now

      Glenn Merlino, Keith Flaherty, Nicolas Acquavella, Chi-Ping Day, Andrew Aplin, Sheri Holmen, Suzanne Topalian, Terry Van Dyke and Meenhard Herlyn

      Article first published online: 8 APR 2013 | DOI: 10.1111/pcmr.12099

  18. News and Views

    1. Crossing the junction in the gap of melanoma brain metastasis

      Takafumi Kamiya, Aaron K. Mobley and Menashe Bar-Eli

      Article first published online: 4 APR 2013 | DOI: 10.1111/pcmr.12095

    2. Regulatory T cells get nervous in the melanoma microenvironment

      Thomas Tueting

      Article first published online: 2 APR 2013 | DOI: 10.1111/pcmr.12093

  19. Signaling & Cell biology

    1. Original Articles

      The PKD domain distinguishes the trafficking and amyloidogenic properties of the pigment cell protein PMEL and its homologue GPNMB

      Alexander C. Theos, Brenda Watt, Dawn C. Harper, Karolina J. Janczura, Sarah C. Theos, Kathryn E. Herman and Michael S. Marks

      Article first published online: 2 APR 2013 | DOI: 10.1111/pcmr.12084

SEARCH

SEARCH BY CITATION